These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 33396209)
21. Circulating exosomal miRNAs: clinical significance in human cancers. Avgeris M; Panoutsopoulou K; Papadimitriou MA; Scorilas A Expert Rev Mol Diagn; 2019 Nov; 19(11):979-995. PubMed ID: 31594418 [No Abstract] [Full Text] [Related]
22. Circulating exosomal miRNAs as a promising diagnostic biomarker in cancer. Lohajová Behulová R; Bugalová A; Bugala J; Struhárňanská E; Šafranek M; Juráš I Physiol Res; 2023 Oct; 72(S3):S193-S207. PubMed ID: 37888964 [TBL] [Abstract][Full Text] [Related]
23. The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer. Aboutalebi H; Bahrami A; Soleimani A; Saeedi N; Rahmani F; Khazaei M; Fiuji H; Shafiee M; Ferns GA; Avan A; Hassanian SM Int J Biochem Cell Biol; 2020 Jul; 124():105765. PubMed ID: 32428568 [TBL] [Abstract][Full Text] [Related]
24. Exosomes as potential sources of biomarkers in colorectal cancer. Xiao Y; Zhong J; Zhong B; Huang J; Jiang L; Jiang Y; Yuan J; Sun J; Dai L; Yang C; Li Z; Wang J; Zhong T Cancer Lett; 2020 Apr; 476():13-22. PubMed ID: 32044357 [TBL] [Abstract][Full Text] [Related]
25. Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients. Fesler A; Jiang J; Zhai H; Ju J Mol Diagn Ther; 2014 Jun; 18(3):303-8. PubMed ID: 24566942 [TBL] [Abstract][Full Text] [Related]
26. Tumor-derived exosomal miRNA-320d as a biomarker for metastatic colorectal cancer. Tang Y; Zhao Y; Song X; Song X; Niu L; Xie L J Clin Lab Anal; 2019 Nov; 33(9):e23004. PubMed ID: 31420913 [TBL] [Abstract][Full Text] [Related]
27. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis. Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288 [TBL] [Abstract][Full Text] [Related]
28. MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review. Toiyama Y; Okugawa Y; Fleshman J; Richard Boland C; Goel A Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):274-282. PubMed ID: 29852194 [TBL] [Abstract][Full Text] [Related]
29. Exosomal miRNAs in colorectal cancer: the carriers of useful news. Sur D; Coza O; Havasi A; Cainap C; Burz C; Vlad C; Balacescu O; Alexandru I; Lisencu C J BUON; 2020; 25(1):23-34. PubMed ID: 32277611 [TBL] [Abstract][Full Text] [Related]
30. Expression profiles of exosomal miRNAs isolated from plasma of patients with desmoplastic small round cell tumor. Colletti M; Paolini A; Galardi A; Di Paolo V; Pascucci L; Russo I; De Angelis B; Peinado H; De Vito R; Milano GM; Locatelli F; Masotti A; Di Giannatale A Epigenomics; 2019 Apr; 11(5):489-500. PubMed ID: 30569756 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic and diagnostic applications of exosomes in colorectal cancer. Shakerian N; Darzi-Eslam E; Afsharnoori F; Bana N; Noorabad Ghahroodi F; Tarin M; Mard-Soltani M; Khalesi B; Hashemi ZS; Khalili S Med Oncol; 2024 Jul; 41(8):203. PubMed ID: 39031221 [TBL] [Abstract][Full Text] [Related]
32. Aberrant circulating tumor DNA methylation and exosomal microRNA biomarkers for early detection of colorectal cancer. Zhang X; Hou H; Jiang M; Zhang X Mol Biol Rep; 2023 Mar; 50(3):2743-2750. PubMed ID: 36583782 [TBL] [Abstract][Full Text] [Related]
33. Revealing the role of serum exosomal novel long non-coding RNA NAMPT-AS as a promising diagnostic/prognostic biomarker in colorectal cancer patients. Rizk NI; Kassem DH; Abulsoud AI; AbdelHalim S; Yasser MB; Kamal MM; Hamdy NM Life Sci; 2024 Sep; 352():122850. PubMed ID: 38901687 [TBL] [Abstract][Full Text] [Related]
34. Current and New Predictors for Treatment Response in Metastatic Colorectal Cancer. The Role of Circulating miRNAs as Biomarkers. Gherman A; Balacescu L; Gheorghe-Cetean S; Vlad C; Balacescu O; Irimie A; Lisencu C Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32197436 [TBL] [Abstract][Full Text] [Related]
35. The Incredible Potential of Exosomes as Biomarkers in the Diagnosis of Colorectal Cancer. Bhattacharya S Curr Drug Res Rev; 2022; 14(3):188-202. PubMed ID: 35490434 [TBL] [Abstract][Full Text] [Related]
36. The potential prognostic and therapeutic application of tissue and circulating microRNAs in cervical cancer. Hasanzadeh M; Movahedi M; Rejali M; Maleki F; Moetamani-Ahmadi M; Seifi S; Hosseini Z; Khazaei M; Amerizadeh F; Ferns GA; Rezayi M; Avan A J Cell Physiol; 2019 Feb; 234(2):1289-1294. PubMed ID: 30191988 [TBL] [Abstract][Full Text] [Related]
37. Exosomal noncoding RNAs in colorectal cancer. Wu Q; Liu W; Wang J; Zhu L; Wang Z; Peng Y Cancer Lett; 2020 Nov; 493():228-235. PubMed ID: 32898600 [TBL] [Abstract][Full Text] [Related]
38. Exosomal miRNAs as Biomarkers of Cancer: a Meta-Analysis. Yang B; Xiong WY; Hou HJ; Xu Q; Cai XL; Zeng TX; Ha XQ Clin Lab; 2019 May; 65(5):. PubMed ID: 31115208 [TBL] [Abstract][Full Text] [Related]
39. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer. Nedaeinia R; Manian M; Jazayeri MH; Ranjbar M; Salehi R; Sharifi M; Mohaghegh F; Goli M; Jahednia SH; Avan A; Ghayour-Mobarhan M Cancer Gene Ther; 2017 Feb; 24(2):48-56. PubMed ID: 27982021 [TBL] [Abstract][Full Text] [Related]
40. Circulating long non-coding RNA colon cancer-associated transcript 2 protected by exosome as a potential biomarker for colorectal cancer. Wang L; Duan W; Yan S; Xie Y; Wang C Biomed Pharmacother; 2019 May; 113():108758. PubMed ID: 30877883 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]